Post

Vasomune wins FDA fast track designation for lung condition treatment

Vasomune Therapeutics has announced that its novel investigational medicine, AV-001, has received US Food and Drug Administration (FDA) fast track …

Self-amplifying RNA and vaccine innovation: getting from concept to clinic

A GlobalData conducted in 2023 found that, according to 100 healthcare industry professionals, genomics was regarded as the most potentially …

Biotech’s road to recovery with 46% increase in Q1 venture funding

Private biotech venture financing saw a 46% increase in total deal value in the first quarter (Q1) of 2024 compared …

J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase

Johnson & Johnson (J&J) is once again targeting atopic dermatitis, gaining the global rights to Numab Therapeutics’ investigational first-in-class antibody, …

How logistics service providers add value for pharma companies

The pharmaceutical industry faces myriad challenges affecting its supply chain, from stringent regulatory requirements to the urgent need for agility …